Short Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Drops By 33.3%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large drop in short interest in May. As of May 31st, there was short interest totalling 9,000 shares, a drop of 33.3% from the May 15th total of 13,500 shares. Based on an average trading volume of 529,900 shares, the short-interest ratio is presently 0.0 days.

Ono Pharmaceutical Price Performance

Shares of OTCMKTS OPHLY opened at $3.56 on Thursday. Ono Pharmaceutical has a 1-year low of $3.21 and a 1-year high of $5.20. The stock’s 50-day moving average is $3.67 and its 200 day moving average is $3.58.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.